Exploring changes over time and characteristics associated with data retrieval across individual participant data meta-analyses: systematic review

scientific article (publication date: 5 April 2017)

Exploring changes over time and characteristics associated with data retrieval across individual participant data meta-analyses: systematic review is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/BMJ.J1390
P932PMC publication ID5733815
P698PubMed publication ID28381561

P50authorCatrin Tudur SmithQ87140163
P2093author name stringAnthony G Marson
Lisa Williams
Sally Reynolds
Sarah J Nevitt
Becky Davie
P2860cites workEmpirical study of data sharing by authors publishing in PLoS journalsQ21142746
Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures: an individual participant data reviewQ24185852
Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data reviewQ24186327
Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data reviewQ24187872
Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalised onset tonic-clonic seizuresQ24201696
Oxcarbazepine versus phenytoin monotherapy for epilepsyQ24202768
Lamotrigine versus carbamazepine monotherapy for epilepsyQ24244885
Oxcarbazepine versus phenytoin monotherapy for epilepsyQ24246413
Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalized onset tonic-clonic seizuresQ24248718
Carbamazepine versus phenobarbitone monotherapy for epilepsyQ24250193
Access to Patient-Level Data from GlaxoSmithKline Clinical TrialsQ24289276
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trialQ24676550
Participant-Level Data and the New Frontier in Trial TransparencyQ24718196
How should individual participant data (IPD) from publicly funded clinical trials be shared?Q28604049
Opening clinical trial data: are the voluntary data-sharing portals enough?Q28607541
How individual participant data meta-analyses have influenced trial design, conduct, and analysisQ28607751
Predictors of clinical trial data sharing: exploratory analysis of a cross-sectional surveyQ28654786
A failed attempt to conduct an individual patient data meta-analysisQ28655731
Sharing of clinical trial data among trialists: a cross sectional surveyQ28710576
The nuts and bolts of PROSPERO: an international prospective register of systematic reviewsQ28736175
Whose data set is it anyway? Sharing raw data from randomized trialsQ28768500
Individual Participant Data (IPD) Meta-analyses of Randomised Controlled Trials: Guidance on Their UseQ30000075
Individual patient data meta-analysis of randomized anti-epileptic drug monotherapy trialsQ30610862
A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysisQ30669346
To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient dataQ30676636
Why did it take 19 months to retrieve clinical trial data from a non-profit organisation?Q30706142
Distribution and epidemiological characteristics of published individual patient data meta-analysesQ30832212
Data sharing, year 1--access to data from industry-sponsored clinical trialsQ30860404
Carbamazepine versus valproate monotherapy for epilepsyQ30887426
Uptake of systematic reviews and meta-analyses based on individual participant data in clinical practice guidelines: descriptive studyQ30906124
Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD StatementQ30940208
A decade of individual participant data meta-analyses: A review of current practiceQ30975392
Get real in individual participant data (IPD) meta-analysis: a review of the methodologyQ30988193
Are manufacturers sharing data as promised?Q30997496
Meta-analysis of individual patient data from randomized trials: a review of methods used in practice.Q31016826
Carbamazepine versus phenytoin monotherapy for epilepsyQ31083753
Evidence synthesis combining individual patient data and aggregate data: a systematic review identified current practice and possible methodsQ31108600
Individual participant data meta-analyses compared with meta-analyses based on aggregate dataQ31126782
Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.Q31142199
Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.Q31147165
Meta-analysis of individual participant data: rationale, conduct, and reportingQ33530020
Assessment of publication bias, selection bias, and unavailable data in meta-analyses using individual participant data: a database surveyQ34116497
Meta-analysis of the literature or of individual patient data: is there a difference?Q34334544
Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizuresQ34424616
Considerations on Designing Clinical Trials to Evaluate the Place of New Antiepileptic Drugs in the Treatment of Newly Diagnosed and Chronic Patients with EpilepsyQ74791650
Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the member states relating to the implementation of good clinical practice in the conduQ81456691
The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trialQ34611908
Multiple treatment comparisons in epilepsy monotherapy trialsQ34710058
The levels of evidence and their role in evidence-based medicineQ35072317
Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working GroupQ36790212
The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviewsQ37692721
Empirical assessment of effect of publication bias on meta-analyses.Q38630464
Sharing Clinical Trial Data--A Proposal from the International Committee of Medical Journal EditorsQ42672446
Searching for information from unreported trials--amnesty for the past and prospective meta-analyses for the future.Q52901680
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant dataQ57689494
P275copyright licenseCreative Commons AttributionQ6905323
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P921main subjectmeta-analysisQ815382
biomedical investigative techniqueQ66648976
P5008on focus list of Wikimedia projectScienceSourceQ55439927
P304page(s)j1390
P577publication date2017-04-05
P13046publication type of scholarly workreview articleQ7318358
systematic reviewQ1504425
P1433published inThe BMJQ546003
P1476titleExploring changes over time and characteristics associated with data retrieval across individual participant data meta-analyses: systematic review
P478volume357

Reverse relations

cites work (P2860)
Q64904319Diagnosis of obstructive coronary artery disease using computed tomography angiography in patients with stable chest pain depending on clinical probability and in clinically important subgroups: meta-analysis of individual patient data.
Q64091450Evaluation of repositories for sharing individual-participant data from clinical studies
Q47734438Meta-analysis of randomized clinical trials in the era of individual patient data sharing
Q58569369Online Family Problem-solving Treatment for Pediatric Traumatic Brain Injury
Q55345267Systematic reviews and cancer research: a suggested stepwise approach.
Q91990116Trial Corresponding Author Country, Year, and Journal Impact Factor Associated with Data Contribution to IPDMAs

Search more.